Collectively, these results suggested that Sptlc2 deficiency decreases LPS-induced inflammation in vivo and ameliorates sepsis symptoms through attenuating MyD88-directed signal transduction (Fig. 6). This evidence concerns the gene SPTLC2 and Sepsis.